Haseeb Ahmad

R&D

Purespring CEO Haseeb Ahmad discusses transforming the treatment of kidney disease, an area of enormous unmet need, and the company's gene therapy.

News

Novo has moved a step closer to EU approval of its long-acting haemophilia A therapy, Frehemgo, which could be a future blockbuster.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.